kcbd.com Traffic Analytics & Website Stats
kcbd.com is a domain having .com extension. kcbd.com is a arts and entertainment/tv movies and streaming website. kcbd.com gets 489,859 traffic per month, the site is estimated to be worth $183,686.00. Over the last three months, kcbd.com's global ranking has decreased from 114,269 to 136,739. kcbd.com's traffic has decreased by 49.48% compared to last month, which is already a sign. Which countries sent the most traffic to kcbd.com lately? Last month USA was the top country sending traffic to kcbd.com. kcbd.com's audience is 60.27% male and 39.73% female. The largest age group of visitors are 25 - 34 year olds.
- Traffic Report
-
Monthly Unique Visitors:
255,119
-
Monthly Pageviews:
489,859
- Estimated Valuation
-
Income Per Day:
$ 383
-
Estimated Worth:
$ 183,686
- Geography & Country Targeting
-
Countries Total Count:
35
-
Hot Country & Region:
USA
- Search keywords & Backlinks
-
Keywords Total Count:
974
-
Backlinks Sites:
5
- Global Ranks
-
Global Rank:
136,739
-
Country Rank:
841
- Global Rank Change
-
Global Rank Change:
-57,320
-
Country Rank Change:
-9,180
- Web Information
- HTTP Information
- Whois Information
Web Server Information
-
Hosted IP Address:
184.73.189.53
-
Hosted Country:
US
-
Location Latitude:
39.043701171875
-
Location Longitude:
-77.474197387695
Page Title of kcbd.com
Home
Meta Description of kcbd.com
KCBD is the South Plains' breaking news and severe weather forecasting leader for Lubbock, Levelland, Brownfield, Plainview, Tahoka, Post, Crosbyton and the surrounding communities.
Meta Tags of kcbd.com
Lubbock Levelland Brownfield Plainview Tahoka Post Crosbyton South Plains Texas Tech University West Texas KCBD Investigates Weather First Alert
Website Inpage Analysis
-
H1 Headings:
0
-
H2 Headings:
1
-
H3 Headings:
4
-
H4 Headings:
28
-
H5 Headings:
1
-
H6 Headings:
8
-
Total IFRAMEs:
1
-
Total Images:
9
-
Total Forms:
0
-
Total Scripts:
29
-
Google Adsense:
No Data
-
Google Analytics:
No Data
HTTP Header Analysis
Content-Type: text/html; charset=utf-8
Server: openresty
Content-Encoding: gzip
ETag: W/"8ad18-4JoAUO7T7W1TmC2wrc4mA87vQqg"
Last-Modified: Fri, 04 Nov 2022 15:21:41 GMT
Vary: Accept-Encoding
X-Akamai-Transformed: 9 77112 0 pmb=mRUM,2
Cache-Control: private, max-age=60
Expires: Fri, 04 Nov 2022 15:22:41 GMT
Date: Fri, 04 Nov 2022 15:21:41 GMT
Transfer-Encoding: chunked
Connection: keep-alive
Connection: Transfer-Encoding
Server-Timing: cdn-cache; desc=REVALIDATE
Server-Timing: edge; dur=189
Server-Timing: origin; dur=945
Link:
Link:
Content-Security-Policy: upgrade-insecure-requests
Strict-Transport-Security: max-age=86400
Akamai-True-TTL: -1
Full WHOIS Lookup
Registry Domain ID: 4656968_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-11-02T08:31:21Z
Creation Date: 1996-05-15T04:00:00Z
Registry Expiry Date: 2023-05-16T04:00:00Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: PDNS05.DOMAINCONTROL.COM
Name Server: PDNS06.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2022-11-11T07:47:23Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
Similarly Ranked Websites
-
buy.palacecinemas.com.au
buy.palacecinemas.com.au 83,562 -
Nikos Pekiaridis/NurPhoto via Getty Images(NEW YORK) -- Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday. The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the companies said. The follow-up period for each participant will be six months. "By combining both indications in one vaccine approach, we aim to provide individuals with an efficient way to receive immunization against two severe respiratory diseases with evolving viruses that require vaccine adaptation," Dr. Ugur Sahin, CEO and co-founder of BioNTech, said in a statement. The combination vaccine is based on the currently available bivalent COVID-19 booster and a quadrivalent mRNA flu vaccine, which is designed to protect against four different flu viruses. The phase 1 trial will test for safety, immune response and optimal dose level of the combination vaccine, before moving on to larger trials. The data will also provide insight into the potential of mRNA vaccines to address more than one pathogen, Sahin said. Annaliesa Anderson, senior vice president and chief scientific officer of vaccine research and development for Pfizer, called this an "exciting step in our ongoing journey with BioNTech as we collectively look to transform the prevention of infectious diseases around the world." "Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world causing thousands of deaths and hospitalizations every year," she said in a statement. Studies indicate COVID-19 vaccine efficacy fades over time, though it's not clear if every American will need an annual COVID-19 booster. As scientists continue to assess the need, several companies are at work on creating a single injection each fall that protects against both seasonal flu and COVID-19. In addition to Pfizer, pharmaceutical companies Moderna and Novavax have announced plans to work on a combo shot. Moderna said it anticipates starting clinical trials on a single-dose vaccine that combines a booster against COVID-19 and a booster against flu by the end of the year, with hopes of the vaccine being available for the 2023 season. "We believe this is a very large opportunity that is ahead of us, if we could bring to market a high efficacy pan-respiratory annual booster," Moderna COE Stéphane Bancel said during the Sept. 9 investor meeting. Last year, Novavax enrolled people in a Phase 1/2 study to evaluate the safety, tolerability and immune response of a combination vaccine using the company's seasonal influenza and COVID-19 vaccines. A phase 2 confirmation trial is expected to begin later this year, the company said in October. Copyright © 2022, ABC Audio. All rights reserved.
mycentraloregon.com 1,173,413 -
Offizielle Webseite von Paramount Pictures Germany. Hier findest du aktuelle und zukünftige Informationen über Filme und Trailer!
paramount.de 1,691,703 -
Sports collecting news and features. Original content centered on modern and vintage sports cards and collectibles. Links to items for sale.
sportscollectorsdaily.com 298,959 -
Watch the trailer, find screenings & book tickets for Top Gun on the official site. Now Playing Only In Theatres, brought to you by Paramount Pictures. Directed by: Joseph Kosinski. Starring: Tom Cruise, Miles Teller, Jennifer Connelly, Jon Hamm, Glen Powell, Lewis Pullman, Charles Parnell, Bashir Salahuddin, Monica Barbaro, Jay Ellis, Danny Ramirez, Greg Tarzan Davis, with Ed Harris, and Val Kilmer
topgunmovie.com 199,898 -
ticketsforthe.show
ticketsforthe.show 878,380 -
vupulse makes digital marketing and advertising more effective for marketers, more profitable for brands, and better experiences for consumers.
vupulse.com 414,897 -
experience.cineworld.co.uk
experience.cineworld.co.uk 9,954 -
Encontre todos os artigos mais recentes e veja programas de TV, reportagens e podcasts relacionados com Portugal em portalcascais.pt
portalcascais.pt 3,298,192 -
omniwebticketing5.com
omniwebticketing5.com 293,575